國立高雄大學圖資館 |

登入

回首頁

Psychopharmacology reconsidereda concise guide exploring the limits of diagnosis and treatment /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Psychopharmacology reconsideredby Robert Haim Belmaker, Pesach Lichtenberg.
其他題名:	a concise guide exploring the limits of diagnosis and treatment /
作者:	Belmaker, Robert Haim.
其他作者:	Lichtenberg, Pesach.
出版者:	Cham :Springer International Publishing :2023.
面頁冊數:	xiv, 220 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Psychopharmacology.
電子資源:	https://doi.org/10.1007/978-3-031-40371-2
ISBN:	9783031403712$q(electronic bk.)

Psychopharmacology reconsidereda concise guide exploring the limits of diagnosis and treatment /
Belmaker, Robert Haim.

Psychopharmacology reconsidereda concise guide exploring the limits of diagnosis and treatment /[electronic resource] :by Robert Haim Belmaker, Pesach Lichtenberg. - Cham :Springer International Publishing :2023. - xiv, 220 p. :ill., digital ;24 cm.

This thought-provoking book covers the full range of psychopharmacologic practice in textbook fashion, offering a fresh and comprehensive self-examination. Unlike conventional texts of psychopharmacology, this text speaks directly to clinicians who have started to question the limitations of psychopharmacologic claims and the rigid confines of DSM-5 diagnoses. Drawing from their clinical and research experience as well as new literature, the well-published authors provide a new perspective that encourages readers to reevaluate established practices and embrace that medication is just one component of treatment and has limits. The book could be used by psychiatric residents in their course of study, by clinical psychology students taking a psychopharmacology course, or by psychiatrists curious to get a readable but comprehensive look at new critical viewpoints in psychopharmacology that have changed since they were taught. Many neuroscience students who are looking for a review of clinical effects to guide their basic research may also find the proposed text more useful than those texts that collate clinical trials. Current texts are for specialized scientists or are part of multi-authored texts which list drugs alphabetically with no conceptual framework, or books that pretend that each biochemical drug property has a clear and known clinical result presented in cartoon style. Some lesser known texts for psychology or nursing students are not authoritative. Others aimed at patients or families are too simplistic for clinicians. The authors' goal was to create a unified text expressing their view of psychopharmacology, its evidence base, the unity of its essential principles, and its independence of DSM or ICD diagnosis. Several new history books describe the "rise and fall" of psychopharmacology, the corruption of big pharma and the failure of large controlled clinical trials. Psychopharmacology Reconsidered: A Concise Guide Exploring the Limits of Diagnosis and Treatment ensures that young clinicians are aware of and understand this critical zeitgeist but aware also of the essential core of psychopharmacology and the evidence upon which it rests.

ISBN: 9783031403712$q(electronic bk.)

Standard No.: 10.1007/978-3-031-40371-2doiSubjects--Topical Terms:

252258
Psychopharmacology.

LC Class. No.: RM315 / .B45 2023

Dewey Class. No.: 615.78

Psychopharmacology reconsidereda concise guide exploring the limits of diagnosis and treatment /
LDR:03199nmm a2200313 a 4500 001 652319
003 DE-He213
005 20231018083303.0
006 m d
007 cr nn 008maaau
008 240327s2023 sz s 0 eng d
020 $a 9783031403712$q(electronic bk.)
020 $a 9783031403705$q(paper)
024 7 $a 10.1007/978-3-031-40371-2 $2 doi
035 $a 978-3-031-40371-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RM315 $b .B45 2023
072 7 $a MMH $2 bicssc
072 7 $a MED105000 $2 bisacsh
072 7 $a MKL $2 thema
082 0 4 $a 615.78 $2 23
090 $a RM315 $b .B451 2023
100 1 $a Belmaker, Robert Haim. $3 962798
245 1 0 $a Psychopharmacology reconsidered $h [electronic resource] : $b a concise guide exploring the limits of diagnosis and treatment / $c by Robert Haim Belmaker, Pesach Lichtenberg.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a xiv, 220 p. : $b ill., digital ; $c 24 cm.
520 $a This thought-provoking book covers the full range of psychopharmacologic practice in textbook fashion, offering a fresh and comprehensive self-examination. Unlike conventional texts of psychopharmacology, this text speaks directly to clinicians who have started to question the limitations of psychopharmacologic claims and the rigid confines of DSM-5 diagnoses. Drawing from their clinical and research experience as well as new literature, the well-published authors provide a new perspective that encourages readers to reevaluate established practices and embrace that medication is just one component of treatment and has limits. The book could be used by psychiatric residents in their course of study, by clinical psychology students taking a psychopharmacology course, or by psychiatrists curious to get a readable but comprehensive look at new critical viewpoints in psychopharmacology that have changed since they were taught. Many neuroscience students who are looking for a review of clinical effects to guide their basic research may also find the proposed text more useful than those texts that collate clinical trials. Current texts are for specialized scientists or are part of multi-authored texts which list drugs alphabetically with no conceptual framework, or books that pretend that each biochemical drug property has a clear and known clinical result presented in cartoon style. Some lesser known texts for psychology or nursing students are not authoritative. Others aimed at patients or families are too simplistic for clinicians. The authors' goal was to create a unified text expressing their view of psychopharmacology, its evidence base, the unity of its essential principles, and its independence of DSM or ICD diagnosis. Several new history books describe the "rise and fall" of psychopharmacology, the corruption of big pharma and the failure of large controlled clinical trials. Psychopharmacology Reconsidered: A Concise Guide Exploring the Limits of Diagnosis and Treatment ensures that young clinicians are aware of and understand this critical zeitgeist but aware also of the essential core of psychopharmacology and the evidence upon which it rests.
650 0 $a Psychopharmacology. $3 252258
650 1 4 $a Psychiatry. $3 201470
650 2 4 $a Neurology. $3 211583
650 2 4 $a Neuropharmacology. $3 275141
650 2 4 $a Neurological Disorders. $3 920956
650 2 4 $a Diagnosis. $3 192756
650 2 4 $a Therapeutics. $3 218144
700 1 $a Lichtenberg, Pesach. $3 962799
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-40371-2
950 $a Medicine (SpringerNature-11650)